Literature DB >> 11420196

Bile bilirubin pigment analysis in disorders of bilirubin metabolism in early infancy.

W S Lee1, P J McKiernan, S V Beath, M A Preece, D Baty, D A Kelly, B Burchell, D J Clarke.   

Abstract

BACKGROUND: Early and accurate diagnosis of Crigler-Najjar syndrome, which causes prolonged unconjugated hyperbilirubinaemia in infancy, is important, as orthotopic liver transplantation is the definitive treatment. AIM: To determine whether bilirubin pigment analysis of bile in infants with prolonged unconjugated hyperbilirubinaemia provides useful diagnostic information in the first 3 months of life.
METHODS: Retrospective review of patients with prolonged unconjugated hyperbilirubinaemia referred to the liver unit, Birmingham Children's Hospital, for the diagnosis of Crigler-Najjar syndrome. Bile bilirubin pigment composition was determined by high performance liquid chromatography. Initial diagnoses were made based on the result of bile bilirubin pigment composition. Final diagnoses were made after reviewing the clinical course, response to phenobarbitone, repeat bile bilirubin pigment composition analysis, and genetic studies.
RESULTS: Between 1992 and 1999, nine infants aged less than 3 months of age with prolonged hyperbilirubinaemia underwent bile bilirubin pigment analyses. Based on these, two children were diagnosed with Crigler-Najjar syndrome (CNS) type 1, six with CNS type 2, and one with Gilbert's syndrome. Five children whose initial diagnosis was CNS type 2 had resolution of jaundice and normalisation of serum bilirubin after discontinuing phenobarbitone, and these cases were thought to be normal or to have Gilbert's syndrome. One of the initial cases of CNS type 1 responded to phenobarbitone with an 80% reduction in serum bilirubin consistent with CNS type 2. In all, the diagnoses of six cases needed to be reviewed.
CONCLUSIONS: Early bile pigment analysis, performed during the first 3 months of life, often shows high levels of unconjugated bilirubin or bilirubin monoconjugates, leading to the incorrect diagnosis of both type 1 and type 2 Crigler-Najjar syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420196      PMCID: PMC1718838          DOI: 10.1136/adc.85.1.38

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  Congenital familial nonhemolytic jaundice with kernicterus.

Authors:  J F CRIGLER; V A NAJJAR
Journal:  Pediatrics       Date:  1952-08       Impact factor: 7.124

2.  High-performance liquid chromatographic analysis of bile pigments as their native tetrapyrroles and as their dipyrrolic azosulfanilate derivatives.

Authors:  G B Odell; W S Mogilevsky; G R Gourley
Journal:  J Chromatogr       Date:  1990-08-03

3.  Effect of phenobarbitone on plasma (14C)bilirubin clearance in patients with unconjugated hyperbilirubinaemia.

Authors:  M Black; J Fevery; D Parker; J Jacobson; B H Billing; E R Carson
Journal:  Clin Sci Mol Med       Date:  1974-01

4.  Bilirubin secretion and conjujation in the Crigler-Najjar syndrome type II.

Authors:  E R Gordon; E A Shaffer; A Sass-Kortsak
Journal:  Gastroenterology       Date:  1976-05       Impact factor: 22.682

5.  Postnatal development of uridine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liver.

Authors:  S Onishi; N Kawade; S Itoh; K Isobe; S Sugiyama
Journal:  Biochem J       Date:  1979-12-15       Impact factor: 3.857

Review 6.  Diagnosis and management of Crigler-Najjar syndrome.

Authors:  P L Jansen
Journal:  Eur J Pediatr       Date:  1999-12       Impact factor: 3.183

7.  Serum and bile bilirubin pigments in the differential diagnosis of Crigler-Najjar disease.

Authors:  F F Rubaltelli; A Novello; L Zancan; M T Vilei; M Muraca
Journal:  Pediatrics       Date:  1994-10       Impact factor: 7.124

8.  Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase.

Authors:  J Seppen; P J Bosma; B G Goldhoorn; C T Bakker; J R Chowdhury; N R Chowdhury; P L Jansen; R P Oude Elferink
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

9.  The differential diagnosis of Crigler-Najjar disease, types 1 and 2, by bile pigment analysis.

Authors:  M Sinaasappel; P L Jansen
Journal:  Gastroenterology       Date:  1991-03       Impact factor: 22.682

10.  Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro.

Authors:  L T Erps; J K Ritter; J H Hersh; D Blossom; N C Martin; I S Owens
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

View more
  3 in total

Review 1.  Concise Review: Updated Advances and Current Challenges in Cell Therapy for Inborn Liver Metabolic Defects.

Authors:  Mustapha Najimi; Florence Defresne; Etienne M Sokal
Journal:  Stem Cells Transl Med       Date:  2016-05-31       Impact factor: 6.940

2.  Fine needle aspiration biopsy of thyroid nodules.

Authors:  I S Arda; S Yildirim; B Demirhan; S Firat
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

Review 3.  Inherited disorders of bilirubin clearance.

Authors:  Naureen Memon; Barry I Weinberger; Thomas Hegyi; Lauren M Aleksunes
Journal:  Pediatr Res       Date:  2015-11-23       Impact factor: 3.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.